ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,481.16
      -0.30%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mind Medicine MindMed Inc (MNMD)

      7. Mind Medicine MindMed Inc (MNMD) News

      MNMD

      Mind Medicine MindMed (MNMD)

      Mind Medicine MindMed Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MNMD
      DateTimeSourceHeadlineSymbolCompany
      01/07/20224:40PMPR Newswire (Canada)Stephen Hurst Resigns from MindMed Board of DirectorsNASDAQ:MNMDMind Medicine MindMed Inc
      01/07/20224:40PMPR Newswire (US)Stephen Hurst Resigns from MindMed Board of DirectorsNASDAQ:MNMDMind Medicine MindMed Inc
      01/04/20227:30AMPR Newswire (Canada)MindMed Successfully Completes Phase 1 Clinical Trial of 18-MCNASDAQ:MNMDMind Medicine MindMed Inc
      01/04/20227:30AMPR Newswire (US)MindMed Successfully Completes Phase 1 Clinical Trial of 18-MCNASDAQ:MNMDMind Medicine MindMed Inc
      12/30/20217:30AMPR Newswire (Canada)MindMed to Participate at the LifeSci Partners 11th Annual Corporate Access EventNASDAQ:MNMDMind Medicine MindMed Inc
      12/30/20217:30AMPR Newswire (US)MindMed to Participate at the LifeSci Partners 11th Annual Corporate Access EventNASDAQ:MNMDMind Medicine MindMed Inc
      12/29/20214:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/29/20217:30AMPR Newswire (Canada)MindMed Announces Transitions to Management TeamNASDAQ:MNMDMind Medicine MindMed Inc
      12/29/20217:30AMPR Newswire (US)MindMed Announces Transitions to Management TeamNASDAQ:MNMDMind Medicine MindMed Inc
      12/21/20214:11PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/21/20217:30AMPR Newswire (US)MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
      12/21/20217:30AMPR Newswire (Canada)MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
      12/17/202112:33PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/17/20217:30AMPR Newswire (Canada)MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHDNASDAQ:MNMDMind Medicine MindMed Inc
      12/17/20217:30AMPR Newswire (US)MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHDNASDAQ:MNMDMind Medicine MindMed Inc
      12/14/20217:30AMPR Newswire (Canada)MindMed Appoints Robert Barrow as Chief Executive Officer and DirectorNASDAQ:MNMDMind Medicine MindMed Inc
      12/14/20217:30AMPR Newswire (US)MindMed Appoints Robert Barrow as Chief Executive Officer and DirectorNASDAQ:MNMDMind Medicine MindMed Inc
      12/09/20218:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/09/20217:30AMPR Newswire (US)MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring SystemNASDAQ:MNMDMind Medicine MindMed Inc
      12/09/20217:30AMPR Newswire (Canada)MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring SystemNASDAQ:MNMDMind Medicine MindMed Inc
      12/07/20214:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/02/20218:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      12/02/20217:30AMPR Newswire (US)MindMed to Participate at the Benzinga Global Small Cap ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      12/02/20217:30AMPR Newswire (Canada)MindMed to Participate at the Benzinga Global Small Cap ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
      12/01/20218:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      11/30/20218:27AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      11/30/20217:30AMPR Newswire (Canada)MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybinNASDAQ:MNMDMind Medicine MindMed Inc
      11/30/20217:30AMPR Newswire (US)MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybinNASDAQ:MNMDMind Medicine MindMed Inc
      11/16/20218:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MNMDMind Medicine MindMed Inc
      11/16/20217:30AMPR Newswire (Canada)MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive MeasuresNASDAQ:MNMDMind Medicine MindMed Inc
       Showing the most relevant articles for your search:NASDAQ:MNMD